Rohit Bazaz
Overview
Explore the profile of Rohit Bazaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lodhi S, Dodgson K, Dykes M, Vishwanath V, Bazaz R, Mathur S, et al.
J Laryngol Otol
. 2024 Apr;
138(9):913-920.
PMID: 38644734
Objective: Evidence for necrotising otitis externa (NOE) diagnosis and management is limited, and outcome reporting is heterogeneous. International best practice guidelines were used to develop consensus diagnostic criteria and a...
2.
Kosmidis C, Achira M, Yong J, Harris C, Bazaz R
Mycoses
. 2024 Mar;
67(3):e13716.
PMID: 38503713
Background: Aspergillus nodules are classified as a subset of chronic pulmonary aspergillosis. The optimal management approach is not known as their natural evolution following biopsy, the rate of progression to...
3.
Jjingo C, Bala S, Waack U, Needles M, Bensman T, McMaster O, et al.
Clin Infect Dis
. 2023 Oct;
78(6):1564-1570.
PMID: 37802928
Allergic bronchopulmonary aspergillosis and invasive fungal diseases represent distinct infectious entities that cause significant morbidity and mortality. Currently, administered inhaled antifungal therapies are unapproved, have suboptimal efficacy, and are associated...
4.
Kosmidis C, Smith H, Mollett G, Harris C, Akili S, Bazaz R
Mycoses
. 2023 Aug;
66(11):960-968.
PMID: 37553558
Objectives: Chronic pulmonary aspergillosis (CPA) is associated with significant mortality, and suboptimal antifungal treatment response. We describe predictive factors for treatment response and survival. Methods: We retrospectively analysed clinical, serological...
5.
Bazaz R, Marriott H, Wright C, Chamberlain J, West L, Gelsthorpe C, et al.
Front Cell Infect Microbiol
. 2023 Apr;
13:1090550.
PMID: 37033482
Introduction: Despite epidemiological associations between community acquired pneumonia (CAP) and myocardial infarction, mechanisms that modify cardiovascular disease during CAP are not well defined. In particular, largely due to a lack...
6.
Power N, Lynch F, Denning D, Bazaz R
J Glob Antimicrob Resist
. 2020 Oct;
23:284-285.
PMID: 33091621
No abstract available.
7.
Gomez I, Ward B, Souilhol C, Recarti C, Ariaans M, Johnston J, et al.
Nat Commun
. 2020 Jan;
11(1):214.
PMID: 31924781
Neutrophils are implicated in the pathogenesis of atherosclerosis but are seldom detected in atherosclerotic plaques. We investigated whether neutrophil-derived microvesicles may influence arterial pathophysiology. Here we report that levels of...
8.
Otu A, Bongomin F, Bazaz R, Harris C, Denning D, Kosmidis C
Mycoses
. 2018 Sep;
62(2):152-156.
PMID: 30267594
Background: Intravenous micafungin has been reported as a treatment alternative in patients with chronic pulmonary aspergillosis (CPA) where long-term oral triazole therapy is unfeasible. Objectives: We evaluated the safety and...
9.
Bongomin F, Rodriguez-Goncer I, Lorden C, Otu A, Bazaz R
Med Mycol Case Rep
. 2018 Aug;
22:11-13.
PMID: 30094131
Antifungal agents account for approximately 3% of Drug-Induced Liver Injury (DILI) cases. Isavuconazole is a novel triazole, and experience with long-term use of it is lacking. We report a case...
10.